Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
Trial Parameters
Brief Summary
Clinical observational studies using epidemiologic theories and methods. Through the collection of various clinically relevant data, specific outcomes are evaluated in hematologic transplant patients, providing high quality real-world data for clinical practice, informing public health decision-making, and reducing the burden of disease
Eligibility Criteria
Inclusion Criteria: 1. At least one visit to a stem cell transplant center beginning January 1, 2021 2. Proposed to undergo or have undergone hematopoietic stem cell transplantation Exclusion Criteria: 1. Long-term follow-up information for patients not available for any reason (e.g., unavailable or with serious concomitant disease) according to investigator opinion 2. Due to alcohol and drug addiction thus affecting their ability to follow the requirements of the study 3. Presence of conditions that could jeopardize patient safety or affect their adherence to the protocol, according to the investigator's opinion